Core Viewpoint - The company reported a significant increase in revenue and profit for the year 2025, with revenue reaching 13.821 billion yuan, a 34% year-on-year growth, and a net profit of 1.788 billion yuan, reflecting a 77% increase [1][2]. Revenue and Profit Analysis - The profit growth rate of 77% is more than double the revenue growth rate of 34%, indicating a strong operational leverage effect [2][14]. - The company's gross margin has remained stable over the past three years, fluctuating between 48.36% and 48.54%, suggesting that the increase in profit is not due to improved gross margins [6][7]. Expense Structure - The company's expenses, including sales, management, financial, and R&D costs, have shown a rising trend, with total expenses increasing from 16.59 billion yuan in 2022 to 22.66 billion yuan in 2024, reflecting a growth rate of 31% [9][10]. - In 2024, despite a revenue decline of 10%, expenses continued to rise, leading to a significant increase in the expense ratio from 19.11% to 22.00% [10]. Operational Leverage - The operational leverage effect was evident in 2025, where revenue increased significantly while expenses did not rise at the same rate, allowing for a substantial increase in net profit [14][20]. - The net profit margin improved to 13.66% in 2025, up from 12.05% in 2024, although it remains below the levels seen in 2022 and 2023 [15][16]. Seasonal Trends - The fourth quarter of 2025 saw an extraordinary increase in net profit, attributed to seasonal trends in the medical equipment industry, where Q4 typically experiences a surge in revenue due to budget execution and project completions [17][18]. Future Outlook - The company has identified three key drivers for continued revenue growth, which, if sustained, could lead to further improvements in profit margins and a return to previous levels of profitability [20]. - The ideal scenario for the company involves leveraging its established global teams and R&D platforms to convert past investments into future revenue growth, thereby transforming fixed costs into variable growth opportunities [21].
收入+34%,利润+77%:联影多赚的钱从哪来?